Home › Psychotic Disorders › North Carolina
Psychotic Disorders clinical trials in North Carolina
4 studies for Psychotic Disorders are looking for participants at sites in North Carolina.
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- New Hope Clinical Research, Charlotte
- AMC Research, LLC, Matthews
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 29, 2026 · NCT06540833A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Triad Clinical Trials - 515 College Rd, Greensboro
- AMC Research, LLC - Flourish - PPDS, Matthews
- West Clinical Research, Morehead City
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated May 4, 2026 · NCT05208190Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 4
Ages 45 to 55 · Women · Updated Apr 29, 2026 · NCT05282277From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.